Impact of Medication Adherence on Virologic Failure in A5202: A Randomized, Partially Blinded, Phase 3B Study.

ABSTRACT: In AIDS Clinical Trials Group A5202, participants who reported missing their medication within the past month or not providing adherence reports at both 8 and 24 weeks had 5 times the hazard of virological failure compared to more adherent participants. Adherence interventions should focus on such patients.

SUBMITTER: Parker RA 

PROVIDER: S-EPMC5434358 | biostudies-literature | 2017 Jun

REPOSITORIES: biostudies-literature